Fujiwara Sho, Koyamada Nozomi, Nishimura Ryuichi, Miyazawa Koji, Miyazaki Shukichi
Department of Surgery, Iwate Prefectural Chubu Hospital, Kitakami, JPN.
Cureus. 2024 Feb 26;16(2):e54973. doi: 10.7759/cureus.54973. eCollection 2024 Feb.
Isolated metastatic tumors of the pancreas from other origins are only 2-3% of pancreatic cancers, and renal cell carcinoma is the most common origin of metastasis. It is challenging to differentiate between pancreatic tumors and those with a history of renal cancer to optimize treatment and management of this tumor. Here, we present a case of isolated renal cell cancer metastasis to the pancreas, which occurred 29 years after the radical nephrectomy. Surgical resection and pancreatectomy is a feasible treatment because of the low rate of complication and favorable prognosis. However, isolated metastatic pancreatic cancer from renal cell cancer is rare and has relatively high risk of recurrence. Therefore, a larger sample size is necessary to evaluate long-term oncologic outcomes and to optimize diagnostic and therapeutic strategies.
来自其他原发部位的孤立性胰腺转移瘤仅占胰腺癌的2%-3%，肾细胞癌是最常见的转移原发部位。鉴别胰腺肿瘤与有肾癌病史的肿瘤，以优化该肿瘤的治疗和管理具有挑战性。在此，我们报告一例孤立性肾细胞癌转移至胰腺的病例，该病例发生在根治性肾切除术后29年。手术切除及胰腺切除术是一种可行的治疗方法，因为并发症发生率低且预后良好。然而，肾细胞癌孤立性转移至胰腺较为罕见，且复发风险相对较高。因此，需要更大的样本量来评估长期肿瘤学结局并优化诊断和治疗策略。
